376 related articles for article (PubMed ID: 17178670)
1. Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytes.
Nahavandi M; Tavakkoli F; Millis RM; Wyche MQ; Habib MJ; Tavakoli N
Hematology; 2006 Aug; 11(4):291-4. PubMed ID: 17178670
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: Impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway.
Nader E; Grau M; Fort R; Collins B; Cannas G; Gauthier A; Walpurgis K; Martin C; Bloch W; Poutrel S; Hot A; Renoux C; Thevis M; Joly P; Romana M; Guillot N; Connes P
Nitric Oxide; 2018 Dec; 81():28-35. PubMed ID: 30342855
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea improves nitric oxide bioavailability in humanized sickle cell mice.
Taylor CM; Kasztan M; Sedaka R; Molina PA; Dunaway LS; Pollock JS; Pollock DM
Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R630-R640. PubMed ID: 33624556
[TBL] [Abstract][Full Text] [Related]
4. Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway.
Haynes J; Baliga BS; Obiako B; Ofori-Acquah S; Pace B
Blood; 2004 May; 103(10):3945-50. PubMed ID: 14764535
[TBL] [Abstract][Full Text] [Related]
5. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
Iyamu EW; Cecil R; Parkin L; Woods G; Ohene-Frempong K; Asakura T
Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase.
Webb AJ; Milsom AB; Rathod KS; Chu WL; Qureshi S; Lovell MJ; Lecomte FM; Perrett D; Raimondo C; Khoshbin E; Ahmed Z; Uppal R; Benjamin N; Hobbs AJ; Ahluwalia A
Circ Res; 2008 Oct; 103(9):957-64. PubMed ID: 18818408
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of arginine and hydroxyurea on BFU-E derived colony growth and HbF synthesis in erythroid progenitors isolated from sickle cell blood.
Baliga BS; Haynes J; Obiako B; Mishra N
Cell Mol Biol (Noisy-le-grand); 2010 Jun; 56 Suppl():OL1290-8. PubMed ID: 20937216
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea generates nitric oxide in human erythroid cells: mechanisms for gamma-globin gene activation.
Lou TF; Singh M; Mackie A; Li W; Pace BS
Exp Biol Med (Maywood); 2009 Nov; 234(11):1374-82. PubMed ID: 19657070
[TBL] [Abstract][Full Text] [Related]
9. Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis.
Perner A; Andresen L; Normark M; Fischer-Hansen B; Sørensen S; Eugen-Olsen J; Rask-Madsen J
Gut; 2001 Sep; 49(3):387-94. PubMed ID: 11511561
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-derived nitric oxide production is increased by ATP released from red blood cells incubated with hydroxyurea.
Lockwood SY; Erkal JL; Spence DM
Nitric Oxide; 2014 Apr; 38():1-7. PubMed ID: 24530476
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease.
Morris CR; Vichinsky EP; van Warmerdam J; Machado L; Kepka-Lenhart D; Morris SM; Kuypers FA
J Pediatr Hematol Oncol; 2003 Aug; 25(8):629-34. PubMed ID: 12902916
[TBL] [Abstract][Full Text] [Related]
12. Bimodal effect of nitric oxide in the enzymatic activity of indoleamine 2,3-dioxygenase in human monocytic cells.
López AS; Alegre E; Díaz A; Mugueta C; González A
Immunol Lett; 2006 Aug; 106(2):163-71. PubMed ID: 16797727
[TBL] [Abstract][Full Text] [Related]
13. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
Schindler C; Leuschner S; Schwanebeck U; Kirch W
J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell nitric oxide synthase modulates red blood cell deformability in sickle cell anemia.
Mozar A; Connes P; Collins B; Hardy-Dessources MD; Romana M; Lemonne N; Bloch W; Grau M
Clin Hemorheol Microcirc; 2016 Nov; 64(1):47-53. PubMed ID: 26890236
[TBL] [Abstract][Full Text] [Related]
15. Normal circulating adult human red blood cells contain inactive NOS proteins.
Kang ES; Ford K; Grokulsky G; Wang YB; Chiang TM; Acchiardo SR
J Lab Clin Med; 2000 Jun; 135(6):444-51. PubMed ID: 10850643
[TBL] [Abstract][Full Text] [Related]
16. Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis.
Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Millis RM
Hematology; 2003 Dec; 8(6):421-8. PubMed ID: 14668039
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide in the healing wound: a time-course study.
Lee RH; Efron D; Tantry U; Barbul A
J Surg Res; 2001 Nov; 101(1):104-8. PubMed ID: 11676563
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
Kozlov AV; Sobhian B; Duvigneau JC; Costantino G; Gemeiner M; Nohl H; Redl H; Bahrami S
J Lab Clin Med; 2002 Nov; 140(5):303-11. PubMed ID: 12434131
[TBL] [Abstract][Full Text] [Related]
19. Morphological and physiological study of the cardiac NOS/NO system in the Antarctic (Hb-/Mb-) icefish Chaenocephalus aceratus and in the red-blooded Trematomus bernacchii.
Garofalo F; Amelio D; Cerra MC; Tota B; Sidell BD; Pellegrino D
Nitric Oxide; 2009 Mar; 20(2):69-78. PubMed ID: 19027084
[TBL] [Abstract][Full Text] [Related]
20. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
Huang Z; Louderback JG; King SB; Ballas SK; Kim-Shapiro DB
Am J Hematol; 2001 Jul; 67(3):151-6. PubMed ID: 11391710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
